Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring

@inproceedings{Hert2006MetabolicAA,
  title={Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring},
  author={Marc De Hert and Dominique Van Eyck and Andr{\'e} R. de Nayer},
  year={2006}
}
Epidemiological studies have demonstrated a relevant increased risk of diabetes in schizophrenic patients who are treated with many atypical antipsychotics, irrespective of concomitant weight gain. Numerous case reports and some large retrospective cohort studies have documented an increased risk of diabetes with some second-generation antipsychotics (SGAs), leading different authors to identify patients on SGA as another high-risk group for diabetes in their review articles. An American… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 59 CITATIONS, ESTIMATED 47% COVERAGE

Drug Emergent Metabolic syndrome in patients on Antipsychotic Medication

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Association of metabolic syndrome with schizophrenia

VIEW 4 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

Prevalence and associations of the metabolic syndrome among patients prescribed clozapine

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.

VIEW 3 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Metabolic syndrome in severe mental disorders.

VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2019

CITATION STATISTICS

  • 11 Highly Influenced Citations